|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in Hungary |
|
|
|
|
€ 200,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2008 |
Taille du document : |
33 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Smoking Cessation Aids 2004
13 pages | Juillet 2004 |
Snapdata's US Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US smoking cessation ai |
240,00 €
|
| |
| |
US First Aid 2004
16 pages | Juillet 2004 |
Snapdata's US First Aid 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US first aid market, and covers trea |
240,00 €
|
| |
| |
US Contraceptives 2004
12 pages | Novembre 2004 |
Snapdata's US Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US contraceptive market, and co |
240,00 €
|
| |
| |
UK Cough Cold & Throat Remedies 2004
12 pages | Juillet 2004 |
Snapdata's UK Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK cough, cold an |
240,00 €
|
| |
| |
US Foot Care Products 2004
13 pages | Juillet 2004 |
Snapdata's US Foot Care Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US foot care product market |
240,00 €
|
| |
| |
US Cough Syrup 2004
12 pages | Juillet 2004 |
Snapdata's US Cough Syrup 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough syrup market, and covers |
240,00 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
2 443,75 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
US Antacids 2004
16 pages | Juillet 2004 |
Snapdata's US Antacids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antacid market, and covers antacid |
240,00 €
|
| |
| |
eCompliance - Part 2: The Physician's Perspective
84 pages | Mars 2005 |
IntroductionThe eCompliance market, though immature, is developing rapidly.
The market will continue to grow as novel means of addressing compliance issues through online channels emerge.
Long-t |
3 040,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in Hungary |
|
|
Datamonitor's OTC Pharmaceuticals in Hungary industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
* Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer and/or brand
* Also features market breakdown by distribution channel
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 16
6.5 Substitutes 18
6.6 Rivalry 19
CHAPTER 7 Leading Companies 20
7.1 Pfizer Inc 20
7.2 GlaxoSmithKline Plc 23
7.3 Béres Pharmaceuticals Co. Ltd 27
CHAPTER 8 Distribution 28
CHAPTER 9 Market Forecasts 29
9.1 Market Value Forecast 29
CHAPTER 10 Macroeconomic Indicators 30
CHAPTER 11 Appendix 32
11.1 Methodology 32
11.2 Industry Associations 33
11.3 Related Datamonitor Research 33
LIST OF TABLES
Table 1: Hungary OTC Pharmaceuticals Market Value: $ million, 2003-2007 9
Table 2: Hungary OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: Hungary OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: Hungary OTC Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Pfizer Inc 20
Table 6: Key Financials: Pfizer Inc 22
Table 7: Key Facts: GlaxoSmithKline Plc 23
Table 8: Key Financials: GlaxoSmithKline Plc 26
Table 9: Key Facts: Béres Pharmaceuticals Co. Ltd 27
Table 10: Hungary OTC Pharmaceuticals Distribution: % Share, by Value, 2007 28
Table 11: Hungary OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 29
Table 12: Hungary Size of Population (million) , 2003-2007 30
Table 13: Hungary GDP (Constant 2000 Prices, $ billion), 2003-2007 30
Table 14: Hungary Inflation, 2003-2007 30
Table 15: Hungary Exchange Rate, 2003 31
|
|
|
PPLSEN
|
|
|
|
|
